Outpatient parenteral antibiotic therapy: principles and practice.
暂无分享,去创建一个
R. Seaton | D. Barr | R A Seaton | D A Barr | D. Barr
[1] R. Seaton,et al. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service. , 2011, The Journal of antimicrobial chemotherapy.
[2] J. Watson,et al. Out-patient parenteral antimicrobial therapy--a viable option for the management of cutaneous leishmaniasis. , 1999, QJM : monthly journal of the Association of Physicians.
[3] D. Fisher,et al. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective. , 2009, International journal of antimicrobial agents.
[4] G. Foti,et al. Outpatient Parenteral Antibiotic Therapy for Bone and Joint Infections: An Italian Multicenter Study , 2007, Journal of chemotherapy.
[5] R. Seaton,et al. Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone. , 2005, The Journal of antimicrobial chemotherapy.
[6] R. Seaton,et al. Management of suspected Lyme borreliosis: experience from an outpatient parenteral antibiotic therapy service. , 2013, QJM : monthly journal of the Association of Physicians.
[7] R. Rucker,et al. Outpatient intravenous medications in the management of cystic fibrosis. , 1974, Pediatrics.
[8] P. Matthews,et al. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. , 2007, The Journal of antimicrobial chemotherapy.
[9] H. Fraimow,et al. Adverse effects of outpatient parenteral antibiotic therapy. , 1999, The American journal of medicine.
[10] M. Bennie,et al. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. , 2011, International journal of antimicrobial agents.
[11] R. Seaton,et al. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. , 2012, International journal of antimicrobial agents.
[12] H. Boucher,et al. Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy , 2009, The Journal of antimicrobial chemotherapy.
[13] Donald R Graham,et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] D. Nathwani,et al. Out-patient and home-parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year's experience in Tayside. , 1999, Health bulletin.
[15] K. Lindfield,et al. Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry , 2008, International journal of clinical practice.
[16] H. Wickens,et al. Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series. , 2009, The Journal of antimicrobial chemotherapy.
[17] Jason E. Bowling,et al. Outpatient Parenteral Antimicrobial Therapy , 2013 .
[18] J. Gatell,et al. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study. , 2011, Enfermedades infecciosas y microbiologia clinica.
[19] C. Marra,et al. Cost Analysis of an Adult Outpatient Parenteral Antibiotic Therapy (OPAT) Programme , 2000, PharmacoEconomics.
[20] Hospital in the home: a randomised controlled trial. , 1998, The Medical journal of Australia.
[21] D. Nathwani. The Management of Skin and Soft Tissue Infections: Outpatient Parenteral Antibiotic Therapy in the United Kingdom , 2000, Chemotherapy.
[22] A. Upton,et al. Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital. , 2004, The New Zealand medical journal.
[23] J. Loeffler,et al. Daptomycin for outpatient parenteral antibiotic therapy: a European registry experience. , 2013, International journal of antimicrobial agents.
[24] A. Tice. Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA , 1995, European Journal of Clinical Microbiology and Infectious Diseases.
[25] D. Nathwani,et al. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT). , 2007, International journal of antimicrobial agents.
[26] B. Howden,et al. 5: Hospital‐in‐the‐home treatment of infectious diseases , 2002, The Medical journal of Australia.
[27] T. Peto,et al. Safe intravenous antibiotic therapy at home: experience of a UK based programme. , 1996, The Journal of antimicrobial chemotherapy.
[28] R. Seaton,et al. Enteric fever in returning travellers: role of outpatient parenteral antibiotic therapy. , 2012, The Journal of infection.
[29] R. Seaton,et al. Outpatient parenteral antimicrobial therapy with ceftriaxone, a review , 2012, International Journal of Clinical Pharmacy.
[30] R. Seaton,et al. Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis , 2013, The Journal of antimicrobial chemotherapy.
[31] Hien H. Nguyen. Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] S. Chambers,et al. Primary care Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital , 2004 .
[33] C. Weir,et al. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. , 2011, International journal of antimicrobial agents.
[34] A. Tice,et al. Outpatient parenteral antimicrobial therapy for central nervous system infections. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy , 2004 .
[36] K. Bowker,et al. Use of meropenem 3 g once daily for outpatient treatment of infective exacerbations of bronchiectasis. , 2000, The Journal of antimicrobial chemotherapy.
[37] P. Tambyah,et al. Outpatient parenteral antibiotic therapy in Singapore. , 2006, International journal of antimicrobial agents.
[38] Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study , 2012, European Journal of Clinical Microbiology & Infectious Diseases.
[39] D. Nathwani,et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. , 2012, The Journal of antimicrobial chemotherapy.
[40] H. Doll,et al. Admission avoidance hospital at home. , 2008, The Cochrane database of systematic reviews.
[41] A. Tice. Pharmacoeconomic Considerations in the Ambulatory Use of Parenteral Cephalosporins , 2012, Drugs.
[42] T. Winstanley,et al. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms. , 2010, The Journal of antimicrobial chemotherapy.
[43] G. Woods,et al. Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections. , 2004, The Journal of infection.
[44] S. Dixon,et al. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. , 2009, The Journal of antimicrobial chemotherapy.
[45] R. Seaton,et al. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme. , 2009, The Journal of antimicrobial chemotherapy.